Literature DB >> 21715306

Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

James T B Crawley1, Rens de Groot, Yaozu Xiang, Brenda M Luken, David A Lane.   

Abstract

von Willebrand factor (VWF) is a large adhesive glycoprotein with established functions in hemostasis. It serves as a carrier for factor VIII and acts as a vascular damage sensor by attracting platelets to sites of vessel injury. VWF size is important for this latter function, with larger multimers being more hemostatically active. Functional imbalance in multimer size can variously cause microvascular thrombosis or bleeding. The regulation of VWF multimeric size and platelet-tethering function is carried out by ADAMTS13, a plasma metalloprotease that is constitutively active. Unusually, protease activity of ADAMTS13 is controlled not by natural inhibitors but by conformational changes in its substrate, which are induced when VWF is subject to elevated rheologic shear forces. This transforms VWF from a globular to an elongated protein. This conformational transformation unfolds the VWF A2 domain and reveals cryptic exosites as well as the scissile bond. To enable VWF proteolysis, ADAMTS13 makes multiple interactions that bring the protease to the substrate and position it to engage with the cleavage site as this becomes exposed by shear. This article reviews recent literature on the interaction between these 2 multidomain proteins and provides a summary model to explain proteolytic regulation of VWF by ADAMTS13.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715306      PMCID: PMC3179391          DOI: 10.1182/blood-2011-02-306597

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  84 in total

1.  Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor.

Authors:  A Katsumi; E A Tuley; I Bodó; J E Sadler
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow.

Authors:  Zhenyin Tao; Yongtao Wang; Huiwei Choi; Aubrey Bernardo; Kenji Nishio; J Evan Sadler; José A López; Jing-Fei Dong
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

Review 3.  Three-dimensional domain architecture of the ADAM family proteinases.

Authors:  Soichi Takeda
Journal:  Semin Cell Dev Biol       Date:  2008-07-26       Impact factor: 7.727

4.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

Authors:  C A Siedlecki; B J Lestini; K K Kottke-Marchant; S J Eppell; D L Wilson; R E Marchant
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

5.  The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers.

Authors:  R J Wise; D D Pittman; R I Handin; R J Kaufman; S H Orkin
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Authors:  Koichi Kokame; Yuko Nobe; Yoshihiro Kokubo; Akira Okayama; Toshiyuki Miyata
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

7.  Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1.

Authors:  H M Tsai; I I Sussman; D Ginsburg; H Lankhof; J J Sixma; R L Nagel
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

8.  Basal secretion of von Willebrand factor from human endothelial cells.

Authors:  Jonathan P Giblin; Lindsay J Hewlett; Matthew J Hannah
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

Review 9.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

10.  Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack.

Authors:  J T B Crawley; D A Lane; M Woodward; A Rumley; G D O Lowe
Journal:  J Thromb Haemost       Date:  2008-01-11       Impact factor: 5.824

View more
  93 in total

1.  Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation.

Authors:  Sandra Lopez-Castaneda; Ignacio Valencia-Hernández; Carlos Arean; Daniel Godínez-Hernández; Martha Eva Viveros-Sandoval
Journal:  Clin Appl Thromb Hemost       Date:  2017-06-15       Impact factor: 2.389

Review 2.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

3.  ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery.

Authors:  Haochen Xu; Yongliang Cao; Xing Yang; Ping Cai; Lijing Kang; Ximin Zhu; Haiyu Luo; Lu Lu; Lixiang Wei; Xiaofei Bai; Yuanbo Zhu; Bing-Qiao Zhao; Wenying Fan
Journal:  Blood       Date:  2017-04-20       Impact factor: 22.113

4.  Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case.

Authors:  Daisuke Matsuda; Takeo Toshima; Toru Ikegami; Norifumi Harimoto; Yo-Ichi Yamashita; Tomoharu Yoshizumi; Yuji Soejima; Tetsuo Ikeda; Ken Shirabe; Yoshihiko Maehara
Journal:  Clin J Gastroenterol       Date:  2014-01-29

5.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 6.  von Willebrand factor: at the crossroads of bleeding and thrombosis.

Authors:  Cécile V Denis; Peter J Lenting
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

7.  A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria.

Authors:  Niamh O'Regan; Kristina Gegenbauer; Jamie M O'Sullivan; Sanaz Maleki; Teresa M Brophy; Niall Dalton; Alain Chion; Padraic G Fallon; Georges E Grau; Ulrich Budde; Owen P Smith; Alister G Craig; Roger J S Preston; James S O'Donnell
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

8.  Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.

Authors:  Rana Grillberger; Veronica C Casina; Peter L Turecek; X Long Zheng; Hanspeter Rottensteiner; Friedrich Scheiflinger
Journal:  Haematologica       Date:  2014-02-14       Impact factor: 9.941

Review 9.  Microvascular platforms for the study of platelet-vessel wall interactions.

Authors:  Ying Zheng; Junmei Chen; José A López
Journal:  Thromb Res       Date:  2014-01-07       Impact factor: 3.944

10.  Internal Tensile Force and A2 Domain Unfolding of von Willebrand Factor Multimers in Shear Flow.

Authors:  Michael Morabito; Chuqiao Dong; Wei Wei; Xuanhong Cheng; Xiaohui F Zhang; Alparslan Oztekin; Edmund Webb
Journal:  Biophys J       Date:  2018-09-13       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.